Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,038	2,094	2,280	2,020	4,808	3,067
Market Cap Growth	-8.13%	-8.13%	12.85%	-57.98%	56.78%	43.30%
Enterprise Value	2,910	3,007	3,258	2,493	5,294	3,584
Last Close Price	37.85	38.90	41.32	35.80	81.41	51.26
PE Ratio	17.91	18.41	36.55	15.05	22.94	35.73
Forward PE	16.09	16.66	17.44	10.61	22.27	25.14
PS Ratio	1.70	1.75	1.98	1.94	5.01	3.79
PB Ratio	3.35	3.44	4.18	3.79	9.62	9.45
P/TBV Ratio	-	-	-	41.96	310.95	-
P/FCF Ratio	12.49	12.84	12.82	8.10	25.42	33.96
P/OCF Ratio	10.12	10.40	10.39	7.00	19.20	23.39
EV/Sales Ratio	2.43	2.52	2.83	2.40	5.51	4.43
EV/EBITDA Ratio	11.26	11.99	14.79	8.24	16.95	23.12
EV/EBIT Ratio	13.02	13.54	16.87	8.82	17.89	25.58
EV/FCF Ratio	17.84	18.43	18.31	9.99	27.98	39.69
Debt / Equity Ratio	1.63	1.63	2.01	0.97	1.16	1.87
Debt / EBITDA Ratio	3.85	3.85	4.83	1.69	1.83	3.81
Debt / FCF Ratio	6.07	6.07	6.15	2.07	3.07	6.72
Asset Turnover	0.56	0.56	0.64	0.74	0.73	0.71
Inventory Turnover	1.34	1.34	1.55	1.57	1.56	1.86
Quick Ratio	0.72	0.72	0.75	1.18	1.61	1.39
Current Ratio	1.82	1.82	1.60	2.45	3.34	3.01
Return on Equity (ROE)	19.38%	19.38%	11.24%	25.69%	50.68%	28.21%
Return on Assets (ROA)	6.55%	6.55%	6.76%	12.53%	14.06%	7.72%
Return on Capital (ROIC)	8.58%	8.58%	8.98%	16.60%	18.39%	9.89%
Return on Capital Employed (ROCE)	12.70%	12.70%	10.90%	23.70%	23.60%	12.80%
Earnings Yield	5.58%	5.43%	2.74%	6.64%	4.36%	2.80%
FCF Yield	8.01%	7.79%	7.80%	12.35%	3.93%	2.94%
Dividend Yield	2.38%	2.31%	2.13%	2.93%	2.67%	1.72%
Payout Ratio	41.64%	41.64%	90.64%	87.04%	22.61%	50.19%
Total Shareholder Return	2.38%	2.31%	2.13%	2.93%	2.67%	1.72%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.